PhoreMost
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
The Works unit 7, Cambridge, Cambridgesh...Phone Number
+44 1223856740Website
www.phoremost.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PhoreMost
Started in 2014 and based in Cambridge, United Kingdom, PhoreMost is a company that develops a next-generation phenotypic screening platform.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PhoreMost your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if PhoreMost is spiking on competitors!
Check if PhoreMost has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when PhoreMost launches new products
Earning: See what the market has to say on PhoreMost recently announced quarterly report
PhoreMost, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at PhoreMost
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once PhoreMost has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PhoreMost had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to PhoreMost
Compare insights from companies similar to PhoreMost, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PhoreMost
<$5M
11-50
Private
$68.8M
2014
N/A
Company Profile Activity
Activity Insights
PhoreMost is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PhoreMost is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PhoreMost.
PhoreMost financials insights
Gather financial insights about PhoreMost, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Angel/Seed
$3.8M
2018
Series A
$15M
2024
Series B
$50M
PhoreMost Tech Stack
A closer look at the technologies used by PhoreMost
Most Recent Scoops
Funding
Event
Events
Promotion
Executive Move
Lateral Move
Executive Move
Board of Directors
Funding
PhoreMost News & Media
PhoreMost raises £33M to advance 'Drugging the Undruggable' research
PhoreMost, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, has completed an oversubscribed £33 million Series B investment round.PhoreMost’s SITESEEKER...PhoreMost extends Series B financing to $50M to advance high-value oncology and ...
Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Management Cambridge, UK, 10 September 2024:PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim
CAMBRIDGE, England--(BUSINESS WIRE)--PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first-in-class therapies, to transform patients’ lives. PhoreMost and Boehringer Ingelheim entered a multi-project collaboration back in January 20201. In this second project, PhoreMost is deploying its in-housPhoreMost Introduces GlueSEEKER Platform for Discovery of Molecular Glue Degraders
CAMBRIDGE, England--(BUSINESS WIRE)--PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKER™. The new phenotypic screening platform expands the Company’s capabilities in this emerging therapeutic modality to support the systematic discovery and development of novel molecular glue degraders (MGDs) for targeted protein degradation (TPD). MGDs are an important new class of small molecule drug that exhibit
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding PhoreMost
Sign Up For FreeTo access detailed company insights
Started in 2014 and based in Cambridge, United Kingdom, PhoreMost is a company that develops a next-generation phenotypic screening platform.... Read More
